Delos Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.2K Buy
36
+18
+100% +$7.17K 0.01% 194
2026
Q2
$6.52K Buy
+18
New +$6.16K ﹤0.01% 231
2025
Q1
– Sell
-100
Closed -$26.1K – 59
2024
Q4
$26.1K Hold
100
– – 0.02% 89
2024
Q3
$32.2K Sell
100
-19
-16% -$6.22K 0.03% 89
2024
Q2
$37.2K Hold
119
– – 0.04% 82
2024
Q1
$33.8K Buy
119
+15
+14% +$4.39K 0.04% 73
2023
Q4
$30K Buy
104
+100
+2,500% +$27.2K 0.04% 76
2023
Q3
$1.03K Hold
4
– – ﹤0.01% 219
2023
Q2
$889 Hold
4
– – ﹤0.01% 227
2023
Q1
$967 Hold
4
– – ﹤0.01% 227
2022
Q4
$1.05K Hold
4
– – ﹤0.01% 231
2022
Q3
$1K Buy
+4
New +$970 ﹤0.01% 208

Other funds holding AMGN

Delos Wealth Advisors's AMGN Position: Q3 2026 in Review

Delos Wealth Advisors increased its Amgen (AMGN) stake by 100% in Q3 2026, buying an estimated $7.17K and bringing the position to 36 shares worth $15.2K. The position accounts for 0.01% of the portfolio, ranked #194.

Delos Wealth Advisors first reported a position in AMGN in Q3 2022 and has held it in 12 quarters since. The position peaked at $37.2K in Q2 2024. 3,275 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Delos Wealth Advisors held 36 shares of Amgen worth $15.2K as of Q3 2026.
  • Delos Wealth Advisors bought 18 Amgen shares in Q3 2026, an estimated $7.17K.
  • Amgen made up 0.01% of Delos Wealth Advisors's portfolio in Q3 2026, its #194 holding.
  • Delos Wealth Advisors first reported a position in Amgen in Q3 2022 and has held it in 12 quarters since.
  • Delos Wealth Advisors's Amgen position peaked at $37.2K in Q2 2024.
  • 3,275 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Delos Wealth Advisors's 13F filing for Q3 2026, filed 17 Nov 2026.